Your browser doesn't support javascript.
loading
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Ying, Baoling; Darling, Tamarand L; Desai, Pritesh; Liang, Chieh-Yu; Dmitriev, Igor P; Soudani, Nadia; Bricker, Traci; Kashentseva, Elena A; Harastani, Houda; Raju, Saravanan; Liu, Meizi; Schmidt, Aaron G; Curiel, David T; Boon, Adrianus C M; Diamond, Michael S.
Afiliação
  • Ying B; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Darling TL; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Desai P; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Liang CY; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Dmitriev IP; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Soudani N; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Bricker T; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Kashentseva EA; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Harastani H; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Raju S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Liu M; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Schmidt AG; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Curiel DT; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Boon ACM; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Diamond MS; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Nat Immunol ; 25(3): 578, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38360936

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article